I will read in detail over the weekend. A bit to digest. Must admit I went straight to the last page (disclaimer) to see if it was paid research. Seems like it isn't, but others may pick up on something I missed. A good sign.
I have no objection to the valuation as a significant discount was used in all calculations, whereas the actual outcomes will be binary. Additionally, the valuation as only for ATL1102 in DMD. And a small bit of the voucher. Word is getting out...
Taylor iniitates coverage of ANP with SP target of $0.27 undiluted, page-2
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
